Psilocybin program

The U.S. Patent and Trademark Office (USPTO) has issued a new patent granting IP rights for the novel composition of matter and methods of use on the psilocybin-based molecules series EVM301 to its developer, Enveric Biosciences (NASDAQ: ENVB).  The biotech company is advancing next-generation...

Democrat Reps. Robert Garcia and Earl Blumenauer filed a new bill in Congress that would discourage federal law enforcement and general intervention in states and localities that legalize or decriminalize psilocybin mushrooms. The Validating Independence for State Initiatives on Organic...

Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification Nonprofit medical research organization the Usona Institute shared the results from its Phase 2 trial assessing a single 25mg synthetic psilocybin...

A number of states are moving reform bills concerning the study or straight out legalizing the use of psychedelic substances for therapeutic purposes. Others have already passed legislation and its implementation is underway. A short recap of the latest moves as of Sept. 7: California:...

COMPASS Pathways plc (NASDAQ: CMPS) shared the results from research on the potential of its novel AI technologies to support its proprietary COMP360 psilocybin treatment for Treatment-Resistant Depression (TRD.) COMPASS is oner of the biggest players in the psychedelics biotech...

Nonprofit medical research organization the Usona Institute shared the results from its Phase 2 trial assessing a single 25mg synthetic psilocybin dose for 104 adults with Major Depressive Disorder (MDD,) providing further evidence of the psychedelic’s antidepressant capabilities. Led by...

Ontario-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its quarterly financial statements, management discussion and analysis for the three months ended June 30. The Numbers: Cash and cash equivalents totaled $12.9 (CA$17.5) million in June 30, 2023 compared...

As professional athletes continue to endorse psychedelic-assisted therapy, former Colorado Avalanche defenseman Kyle Quincey is taking it to the next level. He recently announced the building of a psilocybin-assisted therapy center in the state where voters approved the...

Psychedelics biotech giant COMPASS Pathways (NASDAQ: CMPS) has entered into a securities purchase agreement for an initial $125 million and potential additional of $160 million, with a select group of healthcare specialist investors.  Led by TCGX and Aisling Capital and the...

Natural psychedelic drug development company Filament Health (OTCQB: FLHLF) has released its unaudited consolidated, condensed financial results for Q1 2023 ended June 30. Numbers show: Total cash of $860.324 (CA$1.16 million) as of June 30, 2023, compared to the $2.1 million held by Dec. 31...

Novel psychedelic-based drugs biotech Mydecine Innovations Group (OTC: MYCOF) shared its financial results for the six months ended June 30, 2023. Second quarter of FY2023 looks like this: Cash position of $29.987 (CA $40,458) as of June 30, 2023. Three and six months of R&D expenses totaled $...

Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows: Cash and cash equivalents totaled $148.2 million, compared to $143.2 million held in Dec. 31, 2022, and considering this 2023...

A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances with that of classic drugs.  It further eliminates the criteria based on the number of...

Optimi Completes Novel Extraction Process and Files U.S. Prov. Patent Health Canada-licensed psychedelics researcher and formulator Optimi Health Corp. (OTCQX: OPTHF) has successfully completed its proprietary natural psilocybin extraction process under Good Manufacturing Practices (GMP.) A product...

Rose Hill, a Jamaica-based cultivator, supplier and exporter of premium psilocybin products and biomass to research partners and brands is now offering its first wellness retreat program under the name ONE Retreats.  The company has also launched its lab-tested, naturally-derived vegan...